Forecast Period | 2025-2029 |
Market Size (2023) | USD 686.8 Million |
CAGR (2024-2029) | 7.03% |
Fastest Growing Segment | Equipment |
Largest Market | United States |
Market Size (2029) | USD 1034.74 Million |
Market Overview
North America Biopreservation Market was valued at USD 686.8 Million in
2023 and is anticipated to project impressive growth in the forecast period
with a CAGR of 7.03% through 2029. The Biopreservation market has emerged as a
critical player in the field of life sciences and healthcare, revolutionizing
the storage and maintenance of biological materials. Defined as the process of
preserving cells, tissues, or organs outside their natural environment to
extend their viability, Biopreservation has become an indispensable tool across
various industries, including pharmaceuticals, biotechnology, and healthcare. The Biopreservation market is being propelled by several key factors, including the
increasing demand for personalized medicine, growing investments in biobanking
infrastructure, and the expanding field of regenerative medicine. With
advancements in cell therapy, gene therapy, and organ transplantation, the need
for effective preservation solutions has become more pronounced, driving the
market forward.
One of the prominent trends shaping the
biopreservation landscape is the rise of cryopreservation techniques.
Cryopreservation involves storing biological samples at extremely low
temperatures, typically below -130°C, to arrest cellular activity and maintain
sample integrity. This method has gained traction in preserving stem cells,
embryos, and other valuable biological materials, contributing significantly to
the market's growth. The pharmaceutical and biotechnology sectors are major
contributors to the biopreservation market. As these industries continue to
explore innovative therapies and drug development approaches, the demand for
reliable biopreservation methods has surged. Biopreservation plays a pivotal
role in maintaining the stability and efficacy of biological samples used in
research and development, clinical trials, and manufacturing processes.
The applications of biopreservation are diverse,
covering a spectrum of biological materials. In the healthcare sector, the
preservation of organs for transplantation has witnessed significant
advancements. Biopreservation ensures the viability of organs during
transportation and prior to transplantation, addressing the critical challenge
of organ shortages. In addition to organ preservation, biobanking has become a
cornerstone of medical research. Biobanks store and manage a wide range of
biological specimens, including blood, tissues, and DNA, for research purposes.
The North America rise in biobanking initiatives, driven by collaborative
research endeavors and precision medicine initiatives, has contributed
substantially to the expansion of the biopreservation market. The field of
regenerative medicine, characterized by therapies that aim to repair, replace,
or regenerate damaged tissues and organs, heavily relies on biopreservation.
Stem cells, a key component of regenerative medicine, require precise
preservation methods to maintain their therapeutic potential. As regenerative
medicine continues to evolve, so does the demand for advanced biopreservation
solutions.
While the biopreservation market thrives, it faces
challenges related to the high costs associated with advanced preservation
technologies and the need for standardization in storage and transport
protocols. Addressing these challenges presents opportunities for market
players to innovate and collaborate, fostering the development of more
cost-effective and universally applicable solutions.
The growing awareness of the importance of
preserving biological materials, coupled with the increasing prevalence of
chronic diseases, sets the stage for continued expansion of the biopreservation
market. Market participants are poised to capitalize on this momentum by
investing in research and development, strategic collaborations, and technology
advancements. In conclusion, the biopreservation market is a dynamic and
evolving sector at the intersection of healthcare, biotechnology, and research.
As the North America focus on personalized medicine, regenerative therapies,
and advanced drug development intensifies, the role of biopreservation becomes
increasingly pivotal. The market's journey over the next few years promises
continued innovation, addressing challenges, and unlocking new possibilities
for the preservation of biological assets. As the biopreservation market
celebrates its one-year milestone, it stands as a testament to the
indispensable role it plays in shaping the future of medicine and scientific exploration.
Key Market Drivers
Growing Healthcare Expenditure Boosting Development
Of Effective Personalized Diagnostic & Cell & Gene Therapies
The escalating healthcare expenditure worldwide is
proving to be a catalyst for the robust growth of the biopreservation market,
particularly in the realm of personalized diagnostic and cell and gene
therapies. As countries grapple with the increasing burden of chronic diseases
and an aging population, there is a growing recognition of the need for
advanced medical interventions and personalized treatment approaches. This
paradigm shift towards personalized medicine is driving the demand for
effective biopreservation solutions.
The rise of personalized diagnostic techniques,
tailored to individual patient profiles, necessitates the preservation of
biological samples with the utmost precision. Biopreservation ensures the
integrity and viability of these samples, ranging from genetic material to
biomarkers, allowing for accurate and reliable diagnostic results. This
critical role in diagnostics is propelling the adoption of biopreservation
technologies across healthcare systems North Americaly.
The surge in cell and gene therapies,
considered groundbreaking in the treatment of various diseases, has become a
prominent driver for the biopreservation market. These therapies involve the
manipulation and preservation of cellular material, such as stem cells or
genetically modified cells, before being administered to patients. The
effectiveness of these therapies relies heavily on the quality and viability of
preserved biological samples, making biopreservation an integral part of the
development and deployment of advanced medical treatments.
With healthcare expenditure directed towards
cutting-edge therapies and personalized approaches, the biopreservation market
is witnessing increased investment in research and development. This investment
aims to enhance existing preservation technologies, address challenges related
to long-term storage, and cater to the specific requirements of emerging
therapeutic modalities. Consequently, the market is experiencing a positive
feedback loop where growing healthcare expenditure drives technological advancements
in biopreservation, further fueling the progress and success of personalized
diagnostic and cell and gene therapies.
The upward trajectory of healthcare
expenditure North America is intricately linked to the flourishing
biopreservation market. The demand for personalized diagnostic tools and the
rapid expansion of cell and gene therapies are key factors steering this
growth, underscoring the pivotal role of biopreservation in shaping the
landscape of modern healthcare and therapeutic innovations.
Increasing demand for personalized medicine
The surging demand for personalized medicine is a
key driving force propelling the biopreservation market into a new era of
significance and growth. Personalized medicine, also known as precision
medicine, involves tailoring medical treatments to the individual
characteristics of each patient, considering their unique genetic makeup,
lifestyle, and environment. This paradigm shift in healthcare has created a
pressing need for advanced biopreservation solutions to ensure the integrity
and viability of biological samples crucial for personalized diagnostic and
therapeutic interventions.
Biopreservation plays a pivotal role in the storage
and maintenance of biological materials, ranging from tissues and cells to DNA
samples. As personalized medicine relies heavily on precise diagnostics and
individualized therapeutic approaches, the quality and stability of these
biological samples become paramount. Biopreservation ensures that these samples
remain viable over extended periods, allowing for accurate analysis and the
development of targeted treatments tailored to a patient's specific genetic and
molecular profile.
The rise of genomics and advancements in molecular
diagnostics further accentuate the demand for biopreservation. Genetic testing
and molecular profiling are integral components of personalized medicine,
requiring the preservation of genetic material to enable precise analysis and
interpretation. Biopreservation technologies, such as cryopreservation, provide
a means to store these delicate samples at ultra-low temperatures, ensuring
their molecular integrity and functional viability.
The expansion of personalized medicine beyond
oncology to encompass various therapeutic areas, including cardiology,
neurology, and rare diseases, amplifies the need for robust biopreservation
strategies. As the healthcare industry increasingly recognizes the potential of
tailoring treatments to individual patients, the biopreservation market is
positioned at the forefront of enabling these transformative advancements.
The escalating demand for
personalized medicine is a powerful catalyst driving the biopreservation
market. The intricate link between advanced diagnostics, individualized
treatments, and the need for reliable sample preservation underscores the
indispensable role of biopreservation in shaping the landscape of modern
healthcare and facilitating the realization of personalized medicine's full
potential. As this demand continues to grow, the biopreservation market is
poised for sustained expansion and innovation.
Download Free Sample Report
Key Market Challenges
High costs of advanced preservation technologies.
The high costs associated with advanced
preservation technologies pose a significant challenge for the biopreservation
market. While these technologies offer cutting-edge solutions for maintaining
the viability of biological samples, their prohibitive expenses limit
widespread adoption. Research institutions, biobanks, and healthcare facilities
often face budget constraints, hindering their ability to invest in
state-of-the-art preservation methods. This financial barrier impedes the
accessibility of advanced biopreservation technologies, preventing smaller
entities from fully leveraging the benefits. Addressing this challenge requires
concerted efforts to develop cost-effective alternatives and promote
affordability, ensuring that the advantages of advanced preservation reach a
broader spectrum of users in the healthcare and research sectors.
Standardization issues in storage and transport
protocols
Standardization issues in storage and transport
protocols present a significant challenge for the biopreservation market. The
lack of universally accepted guidelines hampers interoperability and
consistency in preserving biological samples. Divergent protocols across
laboratories and institutions create uncertainties in sample quality and
compromise research reproducibility. This lack of standardization also
complicates regulatory compliance and hinders the seamless exchange of samples
between entities. Overcoming this challenge requires collaborative efforts to
establish comprehensive, standardized protocols, ensuring the reliability and
comparability of preserved samples across the biopreservation landscape.
Achieving consensus in storage and transport practices is essential for
advancing the field and fostering broader research collaboration.
Lack of universally accepted preservation
guidelines
The lack of universally accepted preservation
guidelines poses a formidable challenge for the biopreservation market.
Inconsistent protocols and standards across the industry hinder seamless
collaboration, sample exchange, and data reproducibility. This absence of a
standardized framework complicates regulatory compliance and quality assurance,
impacting the reliability of preserved biological samples. Researchers,
biobanks, and healthcare institutions face difficulties in ensuring the
uniformity and integrity of preserved materials. Addressing this challenge
necessitates concerted efforts to establish North Americaly recognized
guidelines, fostering a more cohesive and standardized approach to
biopreservation. Such guidelines are crucial for advancing research, enhancing
sample quality, and promoting broader industry cooperation.
Limited awareness of biopreservation importance
The limited awareness of the importance of
biopreservation presents a notable challenge for the biopreservation market.
Despite its critical role in maintaining the viability of biological samples
for research, diagnostics, and therapeutics, many stakeholders remain unaware
of its significance. This lack of awareness hampers widespread adoption and
investment in biopreservation technologies. Research institutions, healthcare
facilities, and biobanks may underestimate the impact of suboptimal
preservation, leading to compromised sample quality. Overcoming this challenge
requires targeted educational initiatives to raise awareness about the pivotal
role of biopreservation, emphasizing its implications for advancing medical
research, personalized medicine, and the overall quality of healthcare
interventions.
Key Market Trends
Cryopreservation advancements
Cryopreservation advancements stand out as a
pivotal trend in the biopreservation market, revolutionizing the storage and preservation
of biological materials. The development of cutting-edge cryopreservation
technologies, capable of preserving cells, tissues, and organs at ultra-low
temperatures, enhances the longevity and viability of biological samples. This
trend is particularly significant in the context of emerging therapies like
cell and gene therapies, where the quality of preserved material is critical
for successful treatments. The continuous refinement of cryopreservation
techniques not only addresses existing challenges in long-term storage but also
positions the biopreservation market at the forefront of innovation in the
broader landscape of life sciences and healthcare.
Integration of automation
The integration of
automation emerges as a transformative trend in the biopreservation market,
streamlining processes and enhancing efficiency in sample handling and storage.
Automated systems are increasingly replacing manual interventions, reducing the
risk of errors and ensuring standardized procedures. This trend is particularly
beneficial for large-scale biobanking initiatives and research facilities
dealing with a high volume of biological samples. Automated biopreservation
solutions not only improve the precision of storage conditions but also
contribute to significant time and cost savings. As the demand for scalability
and reproducibility grows, the integration of automation remains a key driver
shaping the future of the biopreservation landscape.
Expansion in regenerative
medicine
The expansion in
regenerative medicine signifies a prominent trend in the biopreservation
market, driving increased demand for advanced storage solutions. Regenerative
medicine, with its focus on harnessing the healing potential of cells and
tissues, necessitates precise preservation methods to maintain therapeutic
efficacy. As the field evolves, biopreservation becomes instrumental in storing
and banking vital materials such as stem cells and tissues for regenerative
therapies. This trend not only reflects the growing importance of
biopreservation in cutting-edge medical treatments but also positions the
market as an essential partner in the progress of regenerative medicine,
offering innovative solutions to support the development and application of
groundbreaking therapies.
Growth in biobanking
initiatives
The burgeoning growth in
biobanking initiatives represents a significant trend propelling the
biopreservation market forward. Biobanks, repositories of diverse biological
samples, play a crucial role in advancing medical research and personalized
medicine. This trend intensifies the demand for robust biopreservation
solutions to ensure the integrity and viability of stored specimens. As
biobanking initiatives expand, the market witnesses a surge in
the adoption of advanced preservation technologies. The need for standardized
storage protocols and increased awareness of biopreservation's pivotal role in
maintaining sample quality underscore the symbiotic relationship between the
growth in biobanking initiatives and the continuous evolution of the
biopreservation market.
Segmental Insights
Product Insights
Based on the Product, in the biopreservation
market, the dominance of equipments is evident due to the critical role they play
in ensuring the viability and integrity of biological samples. Biopreservation
products, including storage media, cryoprotectants, and containers, serve as
the backbone of preserving cells, tissues, and organs. These products are
indispensable in various applications such as biobanking, regenerative
medicine, and personalized diagnostics. As the market witnesses technological
advancements and increasing demand, the innovation and efficacy of
biopreservation products become central to meeting the diverse needs of
researchers and healthcare professionals. The dominance of biopreservation
products underscores their fundamental importance in driving the market's
growth and evolution.
Application Insights
Regenerative medicine stands out as a dominant
force in the biopreservation market due to its revolutionary approach to
treating diseases and injuries. The success of regenerative therapies heavily
relies on the preservation of vital biological materials such as stem cells and
tissues. Biopreservation becomes paramount in maintaining the potency and
viability of these materials, ensuring their therapeutic efficacy. As
regenerative medicine continues to advance, the demand for sophisticated
biopreservation solutions grows, making it a cornerstone of the market. The
dominance of regenerative medicine underscores biopreservation's pivotal role
in facilitating breakthrough treatments that harness the body's own healing
mechanisms for enhanced patient outcomes.
Download Free Sample Report
Country Insights
The United States holds dominance in the
biopreservation market due to its robust healthcare infrastructure, significant
investments in research and development, and a thriving biotechnology sector.
The country fosters a conducive regulatory environment, encouraging
advancements in biopreservation technologies. With a high prevalence of chronic
diseases, the demand for personalized medicine and innovative cell therapies is
substantial, driving the biopreservation market's growth. Moreover, the U.S.
leads in biobanking initiatives and regenerative medicine, solidifying its
position as a key player. The presence of major biopharmaceutical companies and
academic institutions further contributes to the United States' leadership in
the biopreservation industry.
Recent Development
- In 2024, Merck allocated over USD 321.7 million (EUR 300 million) to establish a new Bioprocessing Production Center in Daejeon, South Korea. This investment represents the largest commitment to date from Merck’s Life Science division in the Asia Pacific region, underscoring the company's dedication to enhancing its capabilities in this rapidly expanding market. Merck anticipates that this investment will generate around 300 new jobs by the end of 2028.
- In 2024, Thermo Fisher Scientific launched its latest series of high-performance ultra-low temperature (ULT) freezers. The Thermo Scientific TSX Universal Series ULT Freezers feature significant improvements in performance, user experience, and energy efficiency. These advancements enable the freezers to seamlessly integrate with diverse laboratory workflows, ushering in a new standard of performance, reliability, and sustainability.
- In 2023, Avantor established a partnership with Tobin Scientific, a premier provider of biopharma cold chain, ambient storage, and transport & logistics services. This collaboration aims to support end-to-end relocations for US biopharma clients, including laboratories, research facilities, and sample transfers. The alliance addresses the increasing demand for intricate logistics solutions with precise temperature control requirements.
Key Market Players
- Azenta US, Inc
- Biomatrica, Inc
- BioLife Solutions Inc
- MVE Biological Solutions
- LabVantage Solutions, Inc
- Taylor-Wharton International LLC
- Thermo Fisher Scientific, Inc
- Panasonic Corporation
- X-Therma Inc
- Princeton Cryotech Inc
|
By Product
|
By
Application
|
By Country
|
|
|
- Regenerative
Medicine
- Bio-banking
- Drug
Discovery
|
- United
States
- Canada
- Mexico
|
Report Scope:
In this report, the North America Biopreservation Market
has been segmented into the following categories, in addition to the industry
trends which have also been detailed below:
- North America Biopreservation Market, By Product:
o Equipment
o Media
o LIMS
- North America Biopreservation Market, By Application:
o Regenerative Medicine
o Bio-banking
o Drug Discovery
- North America
Biopreservation Market, By Country:
o United States
o Canada
o Mexico
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Biopreservation
Market.
Available Customizations:
North America Biopreservation market report
with the given market data, Tech Sci Research offers customizations according
to a company's specific needs. The following customization options are
available for the report:
Company Information
- Detailed analysis and profiling of additional
market players (up to five).
North America Biopreservation Market is an upcoming
report to be released soon. If you wish an early delivery of this report or
want to confirm the date of release, please contact us at [email protected]